These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 32865835)
1. Unfolded protein response activation in C9orf72 frontotemporal dementia is associated with dipeptide pathology and granulovacuolar degeneration in granule cells. Gami-Patel P; van Dijken I; Meeter LH; Melhem S; Morrema THJ; Scheper W; van Swieten JC; Rozemuller AJM; Dijkstra AA; Hoozemans JJM Brain Pathol; 2021 Jan; 31(1):163-173. PubMed ID: 32865835 [TBL] [Abstract][Full Text] [Related]
2. Sense-encoded poly-GR dipeptide repeat proteins correlate to neurodegeneration and uniquely co-localize with TDP-43 in dendrites of repeat-expanded C9orf72 amyotrophic lateral sclerosis. Saberi S; Stauffer JE; Jiang J; Garcia SD; Taylor AE; Schulte D; Ohkubo T; Schloffman CL; Maldonado M; Baughn M; Rodriguez MJ; Pizzo D; Cleveland D; Ravits J Acta Neuropathol; 2018 Mar; 135(3):459-474. PubMed ID: 29196813 [TBL] [Abstract][Full Text] [Related]
3. Soluble and insoluble dipeptide repeat protein measurements in C9orf72-frontotemporal dementia brains show regional differential solubility and correlation of poly-GR with clinical severity. Quaegebeur A; Glaria I; Lashley T; Isaacs AM Acta Neuropathol Commun; 2020 Nov; 8(1):184. PubMed ID: 33168090 [TBL] [Abstract][Full Text] [Related]
4. Neurodegeneration in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9orf72 is linked to TDP-43 pathology and not associated with aggregated forms of dipeptide repeat proteins. Davidson Y; Robinson AC; Liu X; Wu D; Troakes C; Rollinson S; Masuda-Suzukake M; Suzuki G; Nonaka T; Shi J; Tian J; Hamdalla H; Ealing J; Richardson A; Jones M; Pickering-Brown S; Snowden JS; Hasegawa M; Mann DM Neuropathol Appl Neurobiol; 2016 Apr; 42(3):242-54. PubMed ID: 26538301 [TBL] [Abstract][Full Text] [Related]
5. Increased prevalence of granulovacuolar degeneration in C9orf72 mutation. Riku Y; Duyckaerts C; Boluda S; Plu I; Le Ber I; Millecamps S; Salachas F; ; Yoshida M; Ando T; Katsuno M; Sobue G; Seilhean D Acta Neuropathol; 2019 Nov; 138(5):783-793. PubMed ID: 31144027 [TBL] [Abstract][Full Text] [Related]
6. Circadian sleep/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases. Dedeene L; Van Schoor E; Vandenberghe R; Van Damme P; Poesen K; Thal DR Acta Neuropathol Commun; 2019 Dec; 7(1):189. PubMed ID: 31791419 [TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers. Mackenzie IR; Frick P; Grässer FA; Gendron TF; Petrucelli L; Cashman NR; Edbauer D; Kremmer E; Prudlo J; Troost D; Neumann M Acta Neuropathol; 2015 Dec; 130(6):845-61. PubMed ID: 26374446 [TBL] [Abstract][Full Text] [Related]
8. Basal parasympathetic deficits in C9orf72 hexanucleotide repeat expansion carriers relate to smaller frontoinsula and thalamus volume and lower empathy. R K Roy A; Noohi F; Morris NA; Ljubenkov P; Heuer H; Fong J; Hall M; Lario Lago A; Rankin KP; Miller BL; Boxer AL; Rosen HJ; Seeley WW; Perry DC; Yokoyama JS; Lee SE; Sturm VE Neuroimage Clin; 2024; 43():103649. PubMed ID: 39098187 [TBL] [Abstract][Full Text] [Related]
9. Stable transgenic C9orf72 zebrafish model key aspects of the ALS/FTD phenotype and reveal novel pathological features. Shaw MP; Higginbottom A; McGown A; Castelli LM; James E; Hautbergue GM; Shaw PJ; Ramesh TM Acta Neuropathol Commun; 2018 Nov; 6(1):125. PubMed ID: 30454072 [TBL] [Abstract][Full Text] [Related]
10. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration. Solomon DA; Stepto A; Au WH; Adachi Y; Diaper DC; Hall R; Rekhi A; Boudi A; Tziortzouda P; Lee YB; Smith B; Bridi JC; Spinelli G; Dearlove J; Humphrey DM; Gallo JM; Troakes C; Fanto M; Soller M; Rogelj B; Parsons RB; Shaw CE; Hortobágyi T; Hirth F Brain; 2018 Oct; 141(10):2908-2924. PubMed ID: 30239641 [TBL] [Abstract][Full Text] [Related]
11. Understanding the relationship between cerebellum and the frontal-cortex region of C9orf72-related amyotrophic lateral sclerosis: A comparative analysis of genetic features. Prasad K; Hassan MI; Raghuvanshi S; Kumar V PLoS One; 2024; 19(5):e0301267. PubMed ID: 38753768 [TBL] [Abstract][Full Text] [Related]
13. Necrosome-positive granulovacuolar degeneration is associated with TDP-43 pathological lesions in the hippocampus of ALS/FTLD cases. Van Schoor E; Koper MJ; Ospitalieri S; Dedeene L; Tomé SO; Vandenberghe R; Brenner D; Otto M; Weishaupt J; Ludolph AC; Van Damme P; Van Den Bosch L; Thal DR Neuropathol Appl Neurobiol; 2021 Feb; 47(2):328-345. PubMed ID: 32949047 [TBL] [Abstract][Full Text] [Related]
14. Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis. Köhler C; Dinekov M; Götz J Neurobiol Dis; 2014 Nov; 71():169-79. PubMed ID: 25073087 [TBL] [Abstract][Full Text] [Related]
15. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model. Nguyen L; Montrasio F; Pattamatta A; Tusi SK; Bardhi O; Meyer KD; Hayes L; Nakamura K; Banez-Coronel M; Coyne A; Guo S; Laboissonniere LA; Gu Y; Narayanan S; Smith B; Nitsch RM; Kankel MW; Rushe M; Rothstein J; Zu T; Grimm J; Ranum LPW Neuron; 2020 Feb; 105(4):645-662.e11. PubMed ID: 31831332 [TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical detection of C9orf72 protein in frontotemporal lobar degeneration and motor neurone disease: patterns of immunostaining and an evaluation of commercial antibodies. Davidson YS; Robinson AC; Rollinson S; Pickering-Brown S; Xiao S; Robertson J; Mann DMA Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb; 19(1-2):102-111. PubMed ID: 28766957 [TBL] [Abstract][Full Text] [Related]
17. ZNF598 co-translationally titrates poly(GR) protein implicated in the pathogenesis of C9ORF72-associated ALS/FTD. Park J; Lee J; Kim JH; Lee J; Park H; Lim C Nucleic Acids Res; 2021 Nov; 49(19):11294-11311. PubMed ID: 34551427 [TBL] [Abstract][Full Text] [Related]
18. Aberrant deposition of stress granule-resident proteins linked to C9orf72-associated TDP-43 proteinopathy. Chew J; Cook C; Gendron TF; Jansen-West K; Del Rosso G; Daughrity LM; Castanedes-Casey M; Kurti A; Stankowski JN; Disney MD; Rothstein JD; Dickson DW; Fryer JD; Zhang YJ; Petrucelli L Mol Neurodegener; 2019 Feb; 14(1):9. PubMed ID: 30767771 [TBL] [Abstract][Full Text] [Related]
19. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model. Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504 [TBL] [Abstract][Full Text] [Related]
20. C9orf72 regulates the unfolded protein response and stress granule formation by interacting with eIF2α. Zheng W; Wang K; Wu Y; Yan G; Zhang C; Li Z; Wang L; Chen S Theranostics; 2022; 12(17):7289-7306. PubMed ID: 36438488 [No Abstract] [Full Text] [Related] [Next] [New Search]